BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34842601)

  • 1. Screening of Neonatal UK Dried Blood Spots Using a Duplex SMN1 Screening Assay.
    Adams SP; Gravett E; Kent N; Kricke S; Ifederu A; Scoto M; Samsuddin S; Muntoni F
    Int J Neonatal Screen; 2021 Oct; 7(4):. PubMed ID: 34842601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplex Droplet Digital PCR Method Applicable to Newborn Screening, Carrier Status, and Assessment of Spinal Muscular Atrophy.
    Vidal-Folch N; Gavrilov D; Raymond K; Rinaldo P; Tortorelli S; Matern D; Oglesbee D
    Clin Chem; 2018 Dec; 64(12):1753-1761. PubMed ID: 30352867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot Study on Newborn Screening for Spinal Muscular Atrophy.
    Fonseca H; Ribeiro D; Guimarães F; Pinto C; Marcão A; Sousa C; Carvalho I; Lopes L; Rodrigues D; Rocha H; Vilarinho L
    Endocr Metab Immune Disord Drug Targets; 2023 Sep; ():. PubMed ID: 37711122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic screening of spinal muscular atrophy using a real-time modified COP-PCR technique with dried blood-spot DNA.
    Ar Rochmah M; Harahap NIF; Niba ETE; Nakanishi K; Awano H; Morioka I; Iijima K; Saito T; Saito K; Lai PS; Takeshima Y; Takeuchi A; Bouike Y; Okamoto M; Nishio H; Shinohara M
    Brain Dev; 2017 Oct; 39(9):774-782. PubMed ID: 28522225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a Pilot Newborn Screening Program for Spinal Muscular Atrophy in Saint Petersburg.
    Kiselev A; Maretina M; Shtykalova S; Al-Hilal H; Maslyanyuk N; Plokhih M; Serebryakova E; Frolova M; Shved N; Krylova N; Il'ina A; Freund S; Osinovskaya N; Sultanov I; Egorova A; Lobenskaya A; Koroteev A; Sosnina I; Gorelik Y; Bespalova O; Baranov V; Kogan I; Glotov A
    Int J Neonatal Screen; 2024 Jan; 10(1):. PubMed ID: 38390973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dried Blood Spot Screening System for Spinal Muscular Atrophy with Allele-Specific Polymerase Chain Reaction and Melting Peak Analysis.
    Wijaya YOS; Nishio H; Niba ETE; Shiroshita T; Kato M; Bouike Y; Tode C; Ar Rochmah M; Harahap NIF; Nurputra DK; Okamoto K; Saito T; Takeuchi A; Lai PS; Yamaguchi S; Shinohara M
    Genet Test Mol Biomarkers; 2021 Apr; 25(4):293-301. PubMed ID: 33877896
    [No Abstract]   [Full Text] [Related]  

  • 7. Spinal Muscular Atrophy Type I With False Negative in Newborn Screening: A Case Report.
    Hashimoto K; Yokokawa M; Yamashita D; Yuge K; Otsubo Y
    Cureus; 2023 Jul; 15(7):e42382. PubMed ID: 37621829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technical feasibility of newborn screening for spinal muscular atrophy by next-generation DNA sequencing.
    Shum BOV; Henner I; Cairns A; Pretorius C; Wilgen U; Barahona P; Ungerer JPJ; Bennett G
    Front Genet; 2023; 14():1095600. PubMed ID: 36713073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Rapid, Accurate and Simple Screening Method for Spinal Muscular Atrophy: High-Resolution Melting Analysis Using Dried Blood Spots on Filter Paper.
    Sa'adah N; Harahap NI; Nurputra DK; Rochmah MA; Morikawa S; Nishimura N; Sadewa AH; Astuti I; Haryana SM; Saito T; Saito K; Nishio H
    Clin Lab; 2015; 61(5-6):575-80. PubMed ID: 26118191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PCR-Based Screening of Spinal Muscular Atrophy for Newborn Infants in Hyogo Prefecture, Japan.
    Noguchi Y; Bo R; Nishio H; Matsumoto H; Matsui K; Yano Y; Sugawara M; Ueda G; Wijaya YOS; Niba ETE; Shinohara M; Bouike Y; Takeuchi A; Okamoto K; Saito T; Shimomura H; Lee T; Takeshima Y; Iijima K; Nozu K; Awano H
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Spinal Muscular Atrophy Carrier Status by Determining
    Wijaya YOS; Purevsuren J; Harahap NIF; Niba ETE; Bouike Y; Nurputra DK; Rochmah MA; Thursina C; Hapsara S; Yamaguchi S; Nishio H; Shinohara M
    Int J Neonatal Screen; 2020 Jun; 6(2):43. PubMed ID: 33073034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a Fast, Robust, Inexpensive, Two-Tiered Neonatal Screening Test algorithm on Dried Blood Spots for Spinal Muscular Atrophy.
    Strunk A; Abbes A; Stuitje AR; Hettinga C; Sepers EM; Snetselaar R; Schouten J; Asselman FL; Cuppen I; Lemmink H; van der Pol WL; Engel H
    Int J Neonatal Screen; 2019 Jun; 5(2):21. PubMed ID: 33072980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newborn screening for spinal muscular atrophy in Japan: One year of experience.
    Sawada T; Kido J; Sugawara K; Yoshida S; Ozasa S; Nomura K; Okada K; Fujiyama N; Nakamura K
    Mol Genet Metab Rep; 2022 Sep; 32():100908. PubMed ID: 35942129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal muscular atrophy patient detection and carrier screening using dried blood spots on filter paper.
    Harahap NI; Harahap IS; Kaszynski RH; Nurputra DK; Hartomo TB; Pham HT; Yamamoto T; Morikawa S; Nishimura N; Rusdi I; Widiastuti R; Nishio H
    Genet Test Mol Biomarkers; 2012 Feb; 16(2):123-9. PubMed ID: 21942573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presymptomatic Diagnosis of Spinal Muscular Atrophy Through Newborn Screening.
    Chien YH; Chiang SC; Weng WC; Lee NC; Lin CJ; Hsieh WS; Lee WT; Jong YJ; Ko TM; Hwu WL
    J Pediatr; 2017 Nov; 190():124-129.e1. PubMed ID: 28711173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Spinal Muscular Atrophy Using a Duplexed Real-Time PCR Approach With Locked Nucleic Acid-Modified Primers.
    Pan J; Zhang C; Teng Y; Zeng S; Chen S; Liang D; Li Z; Wu L
    Ann Lab Med; 2021 Jan; 41(1):101-107. PubMed ID: 32829585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot Program of Newborn Screening for 5q Spinal Muscular Atrophy in the Russian Federation.
    Mikhalchuk K; Shchagina O; Chukhrova A; Zabnenkova V; Chausova P; Ryadninskaya N; Vlodavets D; Kutsev SI; Polyakov A
    Int J Neonatal Screen; 2023 May; 9(2):. PubMed ID: 37218894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New-Born Screening for Spinal Muscular Atrophy: Results of a Latvian Pilot Study.
    Gailite L; Sterna O; Konika M; Isakovs A; Isakova J; Micule I; Setlere S; Diriks M; Auzenbaha M
    Int J Neonatal Screen; 2022 Feb; 8(1):. PubMed ID: 35225937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution melting (HRM) analysis as a feasible method for detecting spinal muscular atrophy via dried blood spots.
    Er TK; Kan TM; Su YF; Liu TC; Chang JG; Hung SY; Jong YJ
    Clin Chim Acta; 2012 Nov; 413(21-22):1781-5. PubMed ID: 22771969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SMA screening system using dried blood spots on filter paper: application of COP-PCR to the SMN1 deletion test.
    Kato N; Sa'Adah N; Ar Rochmah M; Harahap NI; Nurputra DK; Sato H; Sadewa AH; Astuti I; Haryana SM; Saito T; Saito K; Nishimura N; Nishio H; Takeuchi A
    Kobe J Med Sci; 2015 Jan; 60(4):E78-85. PubMed ID: 25791416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.